Alvotech (ALVO)
USD 8.31
(-0.18%)
USD 8.31
(-0.18%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -354.86 Million USD | -2.43% |
| 2022 | -346.44 Million USD | -47.14% |
| 2021 | -235.45 Million USD | -71.19% |
| 2020 | -137.53 Million USD | -123.83% |
| 2019 | -61.44 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -72.88 Million USD | 5.53% |
| 2024 Q2 | -53.4 Million USD | 226.05% |
| 2023 Q2 | -92.82 Million USD | 3.58% |
| 2023 Q1 | -96.27 Million USD | -19.17% |
| 2023 FY | -354.86 Million USD | -2.43% |
| 2023 Q3 | -88.6 Million USD | 4.55% |
| 2023 Q4 | -77.15 Million USD | 12.93% |
| 2022 Q1 | -72.26 Million USD | -597.22% |
| 2022 FY | -346.44 Million USD | -47.14% |
| 2022 Q4 | -80.78 Million USD | -295.96% |
| 2022 Q3 | 41.22 Million USD | 131.39% |
| 2022 Q2 | -131.31 Million USD | -81.71% |
| 2021 FY | -235.45 Million USD | -71.19% |
| 2021 Q2 | -573.8 Thousand USD | -5.18% |
| 2021 Q3 | -75.58 Million USD | -13072.36% |
| 2021 Q4 | 14.53 Million USD | 119.23% |
| 2021 Q1 | -545.56 Thousand USD | -131.83% |
| 2020 FY | -137.53 Million USD | -123.83% |
| 2020 Q4 | -235.33 Thousand USD | 99.32% |
| 2020 Q3 | -34.38 Million USD | 0.0% |
| 2020 Q2 | -34.38 Million USD | 0.0% |
| 2020 Q1 | -34.38 Million USD | -123.83% |
| 2019 Q1 | -15.36 Million USD | 0.0% |
| 2019 Q2 | -15.36 Million USD | 0.0% |
| 2019 Q3 | -15.36 Million USD | 0.0% |
| 2019 Q4 | -15.36 Million USD | 0.0% |
| 2019 FY | -61.44 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 166.96 Million USD | 312.541% |
| China SXT Pharmaceuticals, Inc. | -2.51 Million USD | -14008.524% |
| Embecta Corp. | 221.5 Million USD | 260.208% |
| Pacira BioSciences, Inc. | 87.67 Million USD | 504.745% |
| PainReform Ltd. | -9.58 Million USD | -3602.629% |
| Sunshine Biopharma, Inc. | -4.78 Million USD | -7315.629% |
| SCYNEXIS, Inc. | 72.66 Million USD | 588.324% |
| Journey Medical Corporation | -2.07 Million USD | -17018.186% |
| Safety Shot Inc | -12.18 Million USD | -2812.472% |
| Alpha Teknova, Inc. | -35.56 Million USD | -897.835% |
| Bright Green Corporation | -8.89 Million USD | -3891.057% |
| Procaps Group, S.A. | 38.97 Million USD | 1010.528% |
| ANI Pharmaceuticals, Inc. | 46.97 Million USD | 855.487% |
| Aquestive Therapeutics, Inc. | -15.1 Million USD | -2249.755% |
| Cosmos Health Inc. | -21.83 Million USD | -1525.471% |
| Dynavax Technologies Corporation | -37.02 Million USD | -858.356% |
| Esperion Therapeutics, Inc. | -155.56 Million USD | -128.113% |
| Intra-Cellular Therapies, Inc. | -159.38 Million USD | -122.649% |
| Sunshine Biopharma, Inc. | -4.78 Million USD | -7315.629% |
| Theratechnologies Inc. | -10.62 Million USD | -3239.23% |
| Harrow Health, Inc. | 580 Thousand USD | 61282.759% |
| Sonoma Pharmaceuticals, Inc. | -4.7 Million USD | -7448.607% |
| Biofrontera Inc. | -22.67 Million USD | -1464.845% |
| DURECT Corporation | -36.88 Million USD | -862.097% |
| Supernus Pharmaceuticals, Inc. | -5.26 Million USD | -6634.864% |
| Cronos Group Inc. | -81.37 Million USD | -336.077% |
| OptiNose, Inc. | -22.74 Million USD | -1459.961% |
| Ironwood Pharmaceuticals, Inc. | 209.03 Million USD | 269.76% |
| Kala Pharmaceuticals, Inc. | -39.15 Million USD | -806.342% |
| RedHill Biopharma Ltd. | 12.63 Million USD | 2909.215% |
| Organogenesis Holdings Inc. | 12.52 Million USD | 2933.214% |
| Guardion Health Sciences, Inc. | -4.33 Million USD | -8083.442% |
| Cumberland Pharmaceuticals Inc. | -6.21 Million USD | -5613.578% |
| Radius Health, Inc. | -3.92 Million USD | -8941.019% |
| Universe Pharmaceuticals INC | -3.52 Million USD | -9961.887% |
| ProPhase Labs, Inc. | -21.61 Million USD | -1541.882% |
| Phibro Animal Health Corporation | 53.31 Million USD | 765.591% |
| Procaps Group S.A. | 52.32 Million USD | 778.197% |
| TherapeuticsMD, Inc. | -8.52 Million USD | -4063.557% |
| Viatris Inc. | 766.2 Million USD | 146.314% |
| Rockwell Medical, Inc. | -6.67 Million USD | -5220.24% |
| Aytu BioPharma, Inc. | -5.25 Million USD | -6654.092% |
| SIGA Technologies, Inc. | 83.62 Million USD | 524.366% |
| Tilray Brands, Inc. | -174.74 Million USD | -103.073% |
| Lifecore Biomedical, Inc. | 9.33 Million USD | 3903.022% |
| Shineco, Inc. | -17.06 Million USD | -1979.355% |
| PetIQ, Inc. | 60.01 Million USD | 691.286% |
| Regencell Bioscience Holdings Limited | -4.73 Million USD | -7391.673% |
| Incannex Healthcare Limited | -30.04 Million USD | -1081.252% |
| Neurocrine Biosciences, Inc. | 250.9 Million USD | 241.435% |
| Alimera Sciences, Inc. | -1.47 Million USD | -24023.725% |
| Silver Spike Investment Corp. | 7.34 Million USD | 4934.532% |
| Assertio Holdings, Inc. | -243.53 Million USD | -45.712% |
| Shuttle Pharmaceuticals Holdings, Inc. | -5.89 Million USD | -5922.354% |
| Petros Pharmaceuticals, Inc. | -13.61 Million USD | -2505.938% |
| Clever Leaves Holdings Inc. | -15.59 Million USD | -2175.619% |
| Cyclo Therapeutics, Inc. | -20.05 Million USD | -1669.87% |
| Avadel Pharmaceuticals plc | -137.84 Million USD | -157.427% |
| Hempacco Co., Inc. | -8.81 Million USD | -3926.881% |
| Talphera, Inc. | -16.88 Million USD | -2001.131% |
| Alvotech | -354.86 Million USD | -0.0% |
| Eagle Pharmaceuticals, Inc. | 53.45 Million USD | 763.861% |
| Lantheus Holdings, Inc. | 364.64 Million USD | 197.317% |
| Currenc Group, Inc. | -6.64 Million USD | -5239.625% |
| Kamada Ltd. | 10.06 Million USD | 3626.033% |
| Indivior PLC | -4 Million USD | -8771.5% |
| Evoke Pharma, Inc. | -7.43 Million USD | -4675.47% |
| Flora Growth Corp. | -50.35 Million USD | -604.731% |
| Cyclo Therapeutics, Inc. | -20.05 Million USD | -1669.87% |
| Evolus, Inc. | -49.23 Million USD | -620.777% |
| HUTCHMED (China) Limited | 18.37 Million USD | 2031.211% |
| Amphastar Pharmaceuticals, Inc. | 196.98 Million USD | 280.144% |
| Akanda Corp. | -10.05 Million USD | -3430.463% |